FDA warning letter to Intuitive Surgical over late reporting of da Vinci corrections and adverse events
[REGULATORY ACTION]Jul 19, 2013 · Intuitive Surgical · da Vinci (and Ion) · South Korea
Failure Mode
REGULATORY ACTION
Event Date
Jul 19, 2013
Primary Entity
Intuitive Surgical
Robotic Platform
da Vinci (and Ion)
Jurisdiction / Location
South Korea
Audit Standard
Physical State Verified
Incident Abstract & Audit Findings
After Apr-May 2013 inspections, the FDA issued Intuitive a warning letter (Jul 19 2013) citing it for warning customers about a device correction (Hot Shears) without properly notifying the agency and for MDR-reporting deficiencies. A reporting-compliance regulatory action (distinct from the May 2013 Hot Shears device recall); later closed out. Cap-flag: dated facts corroborated via legal-news sources; the primary FDA letter was not directly retrieved.
System & Fleet Architecture
Operating Manufacturer
Hardware Platform
Operational Sectors
Primary Sources & Evidentiary Filings
- Inspect Filing
https://www.aboutlawsuits.com/intuitve-surgical-warning-da-vinci-problems-51257/
https://www.aboutlawsuits.com/intuitve-surgical-warning-da-vinci-problems-51257/
- Inspect Filing
https://www.theclarkfirmtexas.com/fda-warning-letter-for-intuitive-surgical-robot-manufacturer/
https://www.theclarkfirmtexas.com/fda-warning-letter-for-intuitive-surgical-robot-manufacturer/
- Inspect Filing
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters
Related Incidents & Failure Precedents
6 records on file- NHTSA opens probe into 1.2 million Tesla Model 3 and Model Y vehicles over front suspension failures[REGULATORY ACTION]
Jul 31, 2026 · Tesla · Tesla Robotaxi (Model Y ADS) · Orlando, Florida, USA
Details - NHTSA grants Zoox temporary exemption to commercially deploy up to 2,500 robotaxis annually[REGULATORY ACTION]
Jul 30, 2026 · Zoox · Zoox Robotaxi · Miami
Details - Zoox clears final federal hurdle, receives NHTSA exemption to launch paid robotaxi service[REGULATORY ACTION]
Jul 30, 2026 · Zoox · Zoox Robotaxi · Miami
Details - NHTSA grants Zoox first-ever commercial FMVSS exemption for purpose-built robotaxi[REGULATORY ACTION]
Jul 30, 2026 · Zoox · Zoox Robotaxi · Miami
Details - NHTSA launches $5M SAE ITC partnership to develop first-ever AV performance standards and updates AV technical guidance[REGULATORY ACTION]
Jul 30, 2026 · Zoox · Zoox Robotaxi · Miami
Details - NHTSA grants Zoox temporary commercial deployment exemption for up to 2,500 robotaxis annually for two years[REGULATORY ACTION]
Jul 30, 2026 · Zoox · Zoox Robotaxi · Miami
Details
Incident Context & FAQ
What happened in FDA warning letter to Intuitive Surgical over late reporting of da Vinci corrections and adverse events?
After Apr-May 2013 inspections, the FDA issued Intuitive a warning letter (Jul 19 2013) citing it for warning customers about a device correction (Hot Shears) without properly notifying the agency and for MDR-reporting deficiencies. A reporting-compliance regulatory action (distinct from the May 2013 Hot Shears device recall); later closed out. Cap-flag: dated facts corroborated via legal-news sources; the primary FDA letter was not directly retrieved.
When did this incident occur?
The incident is recorded as occurring on July 19, 2013 on the DEPLOY registry. The date reflects the underlying real-world event, not the registry record's creation date.
What robot was involved in FDA warning letter to Intuitive Surgical over late reporting of da Vinci corrections and adverse events?
da Vinci (and Ion) by Intuitive Surgical is the recorded robot involved in this incident at South Korea.
Has anyone responded to FDA warning letter to Intuitive Surgical over late reporting of da Vinci corrections and adverse events?
No responses to this incident are recorded on the DEPLOY registry. Operators, manufacturers, or affected parties can submit responses to the editorial team; absence is not a guarantee no response was issued.
What is the current status of FDA warning letter to Intuitive Surgical over late reporting of da Vinci corrections and adverse events?
This incident is an active record on the DEPLOY registry; no retraction or correction has been issued.